DEXTROSE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc with a delivery order under contract SPE2DX25D9900, identified by award number SPE2DP26F7330, dated July 11, 2026. The total contract value is $116.52, specifically for the procurement of DEXTROSE INJECTION, identified by NSN 6505015015408 and PR 7017471531. The awardee, DMS PHARMACEUTICAL GROUP INC, operates under CAGE code 1UNB0 and is fulfilling a federal supply requirement within the Department of Defense. The action was posted on the DIBBS portal, reflecting a federal procurement transaction with no designated set-aside classification or NAICS code. The place of performance and office address details are not specified, but the contract is administered under U.S. federal authority.
General Info
Contract Value
$116.52Place of Performance
IL, USASet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
